The investigators framed hysterectomy as a potential modifiable factor in the development of atherosclerotic cardiovascular disease risk. They identified studies reporting new-onset cardiovascular events or metabolic outcomes after surgery. The review included diverse observational designs—cohort and cross-sectional work predominated—and one mixed-design study. Twenty studies were retained from a large initial screen of 18,337 records, which the authors reported as the final evidence base informing pooled estimates.
The cohort of included studies varied by design and outcome measurement. The study team observed that included reports used adjusted effect measures (adjusted odds ratios and adjusted hazard ratios) when available, and pooled results were stratified accordingly. The source did not report randomized trials as eligible findings in the final set; the evidence therefore relies on non-randomized observational data.
Searches ran to March 10, 2026 across PubMed, Cochrane Library, Embase, and ScienceDirect. Study selection and data extraction were performed independently by multiple reviewers, with disagreements resolved by consensus, the authors noted. Cohort studies were appraised with the Newcastle-Ottawa Scale; cross-sectional studies were assessed with a modified instrument. The authors applied a generic inverse-variance random-effects meta-analytic model for outcomes meeting pooling criteria and stratified analyses by study design (cross-sectional versus cohort) and by effect measure (adjusted OR, adjusted HR, or RR). Outcomes that did not meet criteria for meta-analysis were synthesized narratively.
The review reported 11 cohort studies, 8 cross-sectional studies, and a single mixed-design study. The source provided pooled effect estimates for several cardiometabolic endpoints; detailed forest plots and individual-study weights were reported in the manuscript itself, not reproduced here.
Pooled cross-sectional data showed an association between hysterectomy and prevalent hypertension (adjusted OR 1.32, 95% CI 1.18–1.48). Cohort data produced a concordant finding for incident hypertension, with an adjusted HR of 1.19 (95% CI 1.09–1.30), the investigators reported. Both effect measures pointed in the same direction, suggesting higher observed risk of hypertension after surgery across designs.
For diabetes, pooled cross-sectional estimates gave an adjusted OR of 1.21 (95% CI 1.11–1.32), while cohort data indicated an adjusted HR of 1.20 (95% CI 1.13–1.29). The source reported a pooled hazard ratio for hyperlipidemia of 1.21 (95% CI 1.13–1.29), consistent with a modestly elevated incidence in cohort analyses. The meta-analysis also found higher odds for obesity (adjusted OR 1.24, 95% CI 1.03–1.50) and for metabolic syndrome (adjusted OR 1.24, 95% CI 1.08–1.44) in pooled cross-sectional analyses. The authors explicitly linked these outcomes to established atherosclerotic cardiovascular risk factors.
Where the source did not provide pooled estimates or where heterogeneity precluded meta-analysis, the study team presented narrative descriptions of individual-study findings. The abstract and manuscript contain the detailed numerical syntheses and confidence intervals for all pooled outcomes.
The authors evaluated study quality using established observational-study tools. They described stratified pooling by study design and effect measure to reduce heterogeneity from mixing odds ratios with hazard ratios. Residual heterogeneity and limitations inherent to observational evidence remain important caveats. The source did not report randomized evidence among included studies; causal inference is therefore limited by potential confounding and selection bias in the underlying datasets.
The review authors did not report trial-level intervention parameters (such as perioperative management or adjuvant treatments) because such randomized or protocolized interventions were not part of the observational literature summarized. Detailed age-stratified effect estimates or long-term duration thresholds were not summarized in the abstract; interested readers should consult the full manuscript for subgroup and sensitivity analyses.
Based on the pooled associations, the authors recommended active cardiovascular risk assessment and ongoing follow-up for women who undergo hysterectomy, particularly for those operated on at younger ages. The review explicitly links postoperative surveillance to the observed increases in hypertension, diabetes, hyperlipidemia, obesity, and metabolic syndrome.
Unanswered questions remain. The source did not include randomized comparisons to isolate causality, nor did it present uniform age-stratified effect sizes or minimum follow-up durations in the abstract to define when risk accrual becomes clinically significant. The magnitude of residual confounding across included studies and the impact of concurrent oophorectomy or hormonal status on reported associations require further targeted investigation, and the authors noted these gaps in the manuscript. Clinicians and researchers should weigh these evidence limitations when interpreting the associations and when planning prospective, controlled studies to test whether modifying the decision for hysterectomy can alter long-term cardiometabolic trajectories.